Mirae Asset Global Investments Co., Ltd. Ligand Pharmaceuticals Inc Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 745 shares of LGND stock, worth $139,359. This represents 0.0% of its overall portfolio holdings.
Number of Shares
745
Previous 653
14.09%
Holding current value
$139,359
Previous $68,000
23.53%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding LGND
# of Institutions
302Shares Held
19.7MCall Options Held
9KPut Options Held
0-
Black Rock Inc. New York, NY2.87MShares$537 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$391 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.06MShares$198 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3927KShares$173 Million0.13% of portfolio
-
State Street Corp Boston, MA750KShares$140 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $3.16B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...